xestospongin b has been researched along with caffeine in 1 studies
| Studies (xestospongin b) | Trials (xestospongin b) | Recent Studies (post-2010) (xestospongin b) | Studies (caffeine) | Trials (caffeine) | Recent Studies (post-2010) (caffeine) |
|---|---|---|---|---|---|
| 12 | 0 | 5 | 25,501 | 2,393 | 6,825 |
| Protein | Taxonomy | xestospongin b (IC50) | caffeine (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Homo sapiens (human) | 7.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catlin, MC; Costa, LG; Gafni, J; Lam, TH; Molinski, TF; Munsch, JA; Pessah, IN | 1 |
1 other study(ies) available for xestospongin b and caffeine
| Article | Year |
|---|---|
Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor.
Topics: Alkaloids; Animals; Antineoplastic Agents; Astrocytes; Biological Transport; Bradykinin; Caffeine; Calcium; Calcium Channels; Central Nervous System Stimulants; Cytosol; Dose-Response Relationship, Drug; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Ionomycin; Ionophores; Macrocyclic Compounds; Membrane Proteins; Neurons; Oxazoles; PC12 Cells; Porifera; Quinolizines; Rabbits; Rats; Receptors, Cytoplasmic and Nuclear; Ryanodine | 1997 |